Liting Chen, PhD^1*, Zhaofei Wang^2*, Jie Wang^2*, Jin Jin^3*, Jia Wei³, Yicheng Zhang^3* and Peng Fei^2*

¹Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²School of Optical and Electronic Information-Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan, China
³Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Liting Chen, PhD^1*, Qiyang Han^2*, Yan Zhang^3*, Guodan Zeng^3*, Yuekun Fang^2*, Man Zhang^2*, Jia Wei² and Yicheng Zhang^4*

¹Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
³BGI Research, Shenzhen, China
⁴Department of hematopathology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Andrew P Jallouk, MD, PhD¹, Zhongqi Ge, PhD^2*, Vivek Kaimal, PhD^3*, Paul B Robbins, PhD^3*, Zachary J Roberts, MD, PhD^4*, Sattva S. Neelapu, MD⁵ and Pavan Bachireddy, MD⁶

¹Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN
²The University of Texas MD Anderson Cancer Center, Houston, TX
³Allogene Therapeutics, South San Francisco, CA
⁴Allogene Therapeutics, San Francisco, CA
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Hematopoietic Biology & Malignancy, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Kohei Mitsuno^1*, Masaya Suematsu, MD, PhD^2*, Azusa Mayumi, MD, PhD^2*, Hideki Yoshida, MD, PhD^2*, Shinya Osone, MD, PhD^3*, Toshihiko Imamura, MD, PhD², Yozo Nakazawa, MD, PhD^4,5*, Shigeki Yagyu, MD, PhD^2,6* and Tomoko Iehara, MD, PhD^2*

¹Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto-Shi, Japan
²Department of Pediatrics, Kyoto Prefectural University of Medicine, Kyoto, Japan
³Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan
⁴Shinshu University School of Medicine, Matsumoto, JPN
⁵Institute for Biomedical Sciences, Interdisciplinary Cluster for Cutting Edge Research, Shinshu University, Matsumoto, Japan
⁶Innovative Research and Liaison Organization, Shinshu University, Matsumoto, Japan

Zhu Li^1*, Yaling Zheng^1*, Huanyu Wang^1*, Chao Zhang^2*, Li Liu^2*, Lulu Lv, PhD^3* and Li Zhou, PhD^1*

¹Juventas Cell Therapy Ltd, Shanghai, China
²Juventas Cell Therapy Ltd., Shanghai, China
³Juventas Cell Therapy Ltd, Tianjin, China

Martina Magni^1*, Sadhana Jonnalagadda^1*, Giada Zanirato^1*, Silva Ljevar^2*, Francesca Bonifazi^3*, Pier Luigi Zinzani, MD, PhD⁴, Ilaria Cutini^5*, Maria Chiara Tisi^6*, Barbara Botto^7*, Domenico Russo^8*, Giovanni Grillo^9*, Massimo Martino, MD^10*, Mauro Krampera¹¹, Massimo Massaia¹², Patrizia Chiusolo, MD, PhD^13*, Luca Arcaini, MD^14*, Stefania Bramanti^15*, Anna Dodero, MD^16*, Annalisa Chiappella¹, Paolo Corradini, MD¹⁷ and Cristiana Carniti^1*

¹Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
²Unit of Biostatistics for Clinical Research Department of Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
³IRCCS Azienda Ospedaliero-Universitaria, Istituto di Ematologia "L. e A. Seràgnoli", Bologna, Italy
⁴IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
⁵SOD Terapie Cellulari e Medicina Trasfusionale AAD Trapianto di midollo osseo, Ospedale Careggi, Firenze, Italy
⁶Hematology Unit, San Bortolo Hospital, A.U.L.S.S. 8 "Berica", Vicenza, Italy
⁷Hematology Division, A.O.U Città della Salute e della Scienza di Torino, Torino, Italy
⁸Unit of Blood Disease and Stem Cell Transplantation, Department of Clinical and Experimental Sciences, University of Brescia, AO Spedali Civili di Brescia, Brescia, Italy
⁹Department of Hematology and Stem Cell Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
¹⁰Stem Cell Transplant and Cellular Therapies Unit, Hemato-Oncology and Radiotherapy Department, "Bianchi-Melacrino-Morelli"Hospital, Reggio Calabria, Italy
¹¹UOC di Ematologia e Centro Trapianto di Midollo Osseo, Azienda Ospedaliera Universitaria Integrata Verona Policlinico G.B. Rossi, Verona, Italy
¹²SC Ematologia, AO S. Croce e Carle, Cuneo, Italy
¹³UOC Ematologia e Trapianto Cellule Staminali Emopoietiche, Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Rome, Italy
¹⁴Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
¹⁵IRCCS Humanitas Research Hospital, Transplantation Unit Department of Oncology and Haematology, Milan, Italy, Rozzano, Milano, Italy
¹⁶Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy
¹⁷Fondazione IRCCS Istituto Nazionale dei Tumori Milano, University of Milano, Milano, Italy

Tarang Sharma^1*, Maday Galeana Figueroa, MSc^2*, Kishan Nyati, PhD^2*, Meera Mohan, MD², Parameswaran N. Hari, MD, MBBS² and Sabarinath Venniyil Radhakrishnan, MD²

¹Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Wauwatosa, WI
²Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Anna Gurevich Shapiro, MD, MPhil^1,2*, Eitan Winter, PhD^1*, Pascale Zwicky, PhD^1*, Mor Zada, PhD^1*, Noam Shapira, BSc^1*, Oren Barboy, PhD^1*, Paulina Chalan, PhD^1*, Reut Sharet-Eshed, PhD^1*, Merav Kedmi, PhD^3*, Eyal David, PhD^1*, Irit Mazza Avivi, MD^4,5*, Assaf Weiner, PhD^6*, Ron Ram, MD^4,7,8 and Ido Amit, PhD^1*

¹Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel
²Division of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, AL, Israel
³Department of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel
⁴Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁵Division of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
⁶Department of Systems Immunology, Weizmann institute of Science, Rehovot, Israel
⁷Department of Hematology, Tel Aviv medical center, Tel Aviv, Israel
⁸BMT Unit, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel Aviv University, Kfar Haoranim, Israel

Lauren C Cutmore, PhD^1*, Norris Lam, BS^1*, Christina Amatya, PhD^1*, Katherine A Weissler, PhD^2*, Danielle A Natrakul, BS^3* and James N Kochenderfer, MD⁴

¹Surgery Branch, National Cancer Institute, Bethesda, MD
²National Institutes of Health, BETHESDA, MD
³NIH, NCI, Bethesda, MD
⁴Surgery Branch, NCI, Bethesda, MD

Jhang-Sian Yu^1*, Chia-Hung Lin^1*, Ying-Tsen Tung^1*, Fang-Pei Chang^1*, Edward Po-Fan Chu^1*, Shiou-Ling Jian^1*, Fu-Fei Hsu^1*, Ming-Chin Ko^1*, Yi-Han Dai^1*, Chieh-Teng Cheng^1*, Tzu-Chien Kuo^1*, I-Ting Chen^1*, Ting-Yi Wu^1*, Jin-Yi Lu^1*, Ke-Hsun Hsu^1*, Wei-Ting Chen^1*, Darien Zhing Herr Chan^1*, Yi-Ting Lai^2*, Shao-Ju Weng^1*, Liang-Yi Chen^1*, Yuan-Yu Hsia^1*, Yi-Hung Ou^1*, Yo-Chuen Lin^1*, Shih-Wen Huang^1*, Yu-Chih Peng^1*, Chien-Hsi Chen^1*, Chien-Yu Hsu^1*, Yi-Ting Lai^3*, Chih-Lung Chen^1*, Chun-Yu Lin^1*, Lin-Yu Liao^1*, Wan-Chen Tsai^1*, Hsin-Hua Cho^1*, Cheng-Kai Wang^1*, Lee-Yieng Lim^1*, Ji-Kuan Wang^1*, Yao-Yu Chen^1*, Chih-Kai Yin^1*, Wen-Hao Wang^1*, Tsung-Hao Yeh^1*, Min-Ren Chiang^1*, Ruyue Ji^4*, Jen-Chih Chi^1*, Lien-Szu Wu^1*, Jennifer Huang, PhD^1*, De-Kuan Chang^1* and Alex Shih-Min Huang^1*

¹BeiGene, Ltd., Grand Cayman, Cayman Islands
²Functional Assessment, Cell Therapy, BeiGene, Ltd., Grand Cayman, Cayman Islands
³iPSC, Cell Therapy, BeiGene, Ltd., Grand Cayman, Cayman Islands
⁴BeiGene (Shanghai) Co., Ltd., Shanghai, China

Fumou Sun, PhD^1*, Jing Dong, PhD¹, Peiman Hematti, MD², Siegfried Janz, MD, DSc² and Binod Dhakal, MBBS³

¹Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
²Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
³Medical College of Wisconsin, Milwaukee, WI

Siena Nason^1*, Ziqi Yang^1*, Guido Ghilardi, MD^1,2,3*, Luca Paruzzo, MD^1,3*, Alberto Carturan^1*, Eugenio Fardella, MD^1,4*, Puneeth Guruprasad⁵, Anushka Anant Padmanabhan^1*, Tatiana Blanchard^1*, Gerald Linette, MD, PhD^1,6*, Beatriz M. Carreno, PhD^1,6*, Sandra Susanibar-Adaniya, MD⁷, Alfred L. Garfall, MD^7,8,9, Marco Ruella, MD^1,3,8,9 and Patrizia Porazzi, PhD^1,3,9*

¹Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
²Oncology Institute of Southern Switzerland, Philadelphia, PA
³Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁴Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
⁵Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, North Wales, PA
⁶Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, PA
⁷Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁸Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁹Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA

Isabel Lira, BS^1*, Danielle C. Kirkey, MD^1,2, Marilena Nicolaidou, MS^3*, Henrike Muller^3*, Marta Barisa, PhD^3*, Melia Blankenfeld, BS^1*, Grace Hawkins^1*, Cyd McKay^1*, Christina Root^1*, Laura Pardo, MS^4*, Michael R. Loken, PhD^4*, Tiffany Hylkema, BS^1*, Concetta Quintarelli, PhD^5*, Franco Locatelli, MD⁵, John Anderson, PhD^3* and Soheil Meshinchi, MD, PhD¹

¹Translational Science and Therapeutics, Fred Hutchinson Cancer Center, Seattle, WA
²Pediatric Hematology/Oncology, Seattle Children's Hospital, Seattle, WA
³University College London, London, United Kingdom
⁴Hematologics, Inc., Seattle, WA
⁵IRCCS Bambino Gesù Children's Hospital, Rome, Italy

Minghao Li^1*, Wenjie Gong^2,3*, JingWen Tan^1*, Hongjia Zhu^1*, Nan Xu^1*, Liqing Kang^1*, Xiaoyan Lou^1*, Wei Wang^1*, Jing Ye^1*, Zhou Yu^1*, Israth Jahan Tuhin^1*, Liyun Chen^2,3*, Chongsheng Qian^2,3*, Meijing Liu^2,3*, Ni Mei^4*, Tong Shi^5*, Guanghua Chen^2,3, Lei Yu^1*, Shengli Xue^3,6* and Depei Wu, MD, PhD^7,8

¹Shanghai Unicar-Therapy Bio-Medicine Technology Co.,Ltd, Shanghai, China
²Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
³National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
⁴Shanghai Center for Drug Evaluation and Inspection, Shanghai, China
⁵Shanghai Center of Biomedicine Development, Shanghai, China
⁶The first Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center of Hematologic Diseases, Suzhou, China
⁷Institute of Blood and Marrow Transplantation, Suzhou, China
⁸The First Affiliated Hospital of Soochow University, Suzhou, China

Xiao Chai^1*, Xiaomei Zhang^2*, Mingfeng Zhao³ and Rui Zhang^4*

¹The First Central Clinical College of Tianjin Medical University, Tianjin, China
²Medical School of Nankai University, Tianjin, China
³Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China
⁴Tianjin First Central Hospital, Tianjin, China

Adrian Gottschlich, MD^1,2,3,4*, Ruth Grünmeier^2*, Gordon Victor Hoffmann^2*, Sayantan Nandi, PhD^2*, Vladyslav Kavaka, MD^5,6*, Philipp Jie Müller^2*, Jakob Jobst^2*, Arman Öner, MD^2*, Rainer Kaiser, MD^7,8*, Jan Gärtig^2*, Ignazio Piseddu, MD^9,10*, Stephanie Frenz-Wiessner, MD^11*, Heiko Schulz, MD^12*, Lea Di Fina^8*, Maité Mulkers^8*, Moritz Thomas, PhD^13,14*, Veronika Igl^2*, Thomas Alexander Janert^2*, Daria Briukhovetska, PhD^2*, Donjetë Simnica, PhD^2*, Emanuele Carlini^2*, Christina Tsiverioti^2*, Marcel Trefny, PhD^2*, Theo Lorenzini, MD^2*, Florian Märkl, PhD^2*, Ruben Brabenec^2,14*, Thaddäus Strzalkowski^2*, Sophia Stock, MD^2,3,15*, Stefanos Michaelides^2*, Irmela Jeremias, MD^3,11, Johannes Christian Hellmuth, MD^16*, Martin Thelen^17,18*, Sarah Reinke, PhD^19*, Wolfram Klapper, MD, Prof^19*, Pascal Gelebart, PhD^20,21*, Leo Nicolai, MD^7,8*, Carsten Marr, PhD^14*, Eduardo Beltrán, PhD^5,6,22*, Christoph Klein, MD^9,11, Fanny Baran-Marszak, MD, PhD^23,24*, Paul J. Bröckelmann, MD^25*, Andreas Rosenwald, MD^26,27*, Michael von Bergwelt-Baildon, MD, PhD^1,3,4*, Stefan Endres, MD, Prof^2,3,28* and Sebastian Kobold, MD^2,3,28*

¹Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
²Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany
³German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
⁴Bavarian Cancer Research Center (BZKF), Munich, Germany
⁵Institute of Clinical Neuroimmunology, University Hospital, LMU Munich, Munich, Germany
⁶Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Martinsried, Germany
⁷DZHK (German Center for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany
⁸Department of Medicine I, University Hospital, LMU Munich, Munich, Germany
⁹Gene Center and Department of Biochemistry, LMU Munich, Munich, Germany
¹⁰LMU University Hospital, LMU Munich, Department of Medicine II, Munich, Germany
¹¹Department of Pediatrics, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, Munich, Germany
¹²Institute of Pathology, University Hospital, LMU Munich, Munich, DEU
¹³School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany
¹⁴Institute of AI for Health, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
¹⁵Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
¹⁶Department of Medicine III, LMU Munich, Munich, Germany
¹⁷Department of General, Visceral, Cancer and Transplantation Surgery, University of Cologne, Cologne, DEU
¹⁸Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany
¹⁹Department of Pathology, Hematopathology Section, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
²⁰Department of Clinical Science, University of Bergen, Bergen, NOR
²¹Department of Hematology, Haukeland University Hospital, Bergen, Norway
²²Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
²³Service d’Hématologie Biologique, Hôpitaux Universitaire Paris Seine Saint Denis (HUPSSD), Hôpital Avicenne, Université Sorbonne Paris Nord, Bobigny, France
²⁴INSERM U978, University of Paris 13, Bobigny, France
²⁵University of Cologne, Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), and German Hodgkin Study Group (GHSG), Cologne, Germany
²⁶Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany
²⁷Institute of Pathology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany
²⁸Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany

Mirko Farina, MD^1*, Eugenio Galli^2*, Marcello Riva^3*, Ilaria Cutini^4*, Simona Bernardi, PhD^1,5*, Massimo Martino, MD^6*, Silvia Ferrari, MD^7*, Giorgia Battipaglia, MD^8*, Mattia Novo, MD^9*, Maurizio Musso^10*, Giovanni Grillo^11*, Stella Santarone, MD^12*, Mauro Krampera¹³, Andrea Aroldi, MD^14*, Nicola Polverelli¹⁵, Luca Arcaini^15*, Alessandro Re, MD^16*, Besjana Xhahysa^1,5*, Alessandro Leoni^5,17*, Maria Chiara Tisi^3*, Patrizia Chiusolo, MD, PhD^2*, Michele Malagola, MD¹ and Domenico Russo^1*

¹Blood Diseases and Cell Therapies unit, Bone Marrow Transplant Unit, ASST Spedali Civili of Brescia, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
²Dipartimento di Scienze di Laboratorio Ed Ematologiche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Sezione di Ematologia, Dipartimento di Scienze Radiologiche Ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy
³Hematology Unit, San Bortolo Hospital, A.U.L.S.S. 8 "Berica", Vicenza, Italy
⁴SOD Terapie Cellulari e Medicina Trasfusionale, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy
⁵Centro di Ricerca Emato-Oncologica AIL (CREA), ASST Spedali Civili, Brescia, Italy
⁶Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Stem Cell Transplant Program CIC 587, Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano "Bianchi-Melacrino-Morelli”, Presidio Morelli, Viale Europa, 8, Reggio Calabria, Italy
⁷Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Santa Monica, CA
⁸8. Haematology Department and Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy
⁹9. Division of Hematology, AOU Città Della Salute e Della Scienza di Torino, Torino, Italy
¹⁰Hematology Unit, Clinica La Maddalena Division of Onco-Hematology and Stem Cell Transplantation, Palermo, Italy
¹¹Department of Hematology and Stem Cell Transplantation, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
¹²Ospedale Civile, Terapia Intensiva Ematologica- Dipartimento Oncologico Ematologico, Pescara, Italy
¹³Hematology and Bone Marrow Transplant Unit, Section of Biomedicine of Innovation, Department of Engineering for Innovative Medicine, Università di Verona e Azienda Ospedaliera Universitaria di Verona, Verona, Italy
¹⁴Hematology Division and Bone Marrow Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
¹⁵Unit of Bone Marrow Transplantation - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
¹⁶Lymphoma Unit, Division of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹⁷Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy

Maria Luisa Palacios-Berraquero^1*, Paula Rodriguez-Marquez^2*, Maria Erendira Calleja-Cervantes^2,3*, Nerea Berastegui^2*, Aintzane Zabaleta, PhD^2*, Leire Burgos, PhD^2*, Diego Alignani, PhD^2*, Patxi San-Martin^2*, Amaia Vilas-Zornoza^1*, Saray Rodríguez Diaz^2*, Susana Inogés, MD, PhD^1,4,5*, Ascensión López-Díaz De Cerio^1,4,5*, Sofia Huerga^1,6*, Luis-Esteban Tamariz-Amador, MD^1,6*, Jose J. Rifon, M.D.^1,5,6*, Ana Alfonso Pierola, MD, PhD^1,5,7*, Juan J Lasarte, PhD^8*, Bruno Paiva, PhD^2,5,6*, Mikel Hernaez, PhD^3,5,9*, Paula Rodríguez-Otero, MD, PhD^1,5,6*, Jesús F. San-Miguel, MD, PhD^1,2,5,10, Teresa Ezponda^2,11*, Juan Roberto Rodriguez-Madoz, PhD^2,6,12* and Felipe Prosper, MD, PhD^2,6,13,14

¹Hematology and Cell Therapy Department. Clinica Universidad de Navarra. IdiSNA., Pamplona, Spain
²Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
³Computational Biology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
⁴Immunology and Immunotherapy Department. Clinica Universidad de Navarra., Pamplona, Spain
⁵Centro de Investigación Biomedica en Red de Cancer (CIBERONC)., Madrid, Spain
⁶Cancer Center Clinica Universidad de Navarra (CCUN)., Pamplona, Spain
⁷Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain
⁸Immunology and Immunotherapy Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
⁹Center for Data Science and Artificial Intelligence Institute (DATAI), Universidad de Navarra, Pamplona, Pamplona, Spain
¹⁰Cancer Center Clinica Universidad de Navarra, CIMA, IDISNA, Pamplona, Spain
¹¹Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain
¹²Centro de Investigacion Biomedica en Red de Cancer (CIBERONC)., Madrid, Spain
¹³Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain
¹⁴Centro de Investigación Biomedica en Red de Cancer (CIBERONC), Madrid, Spain

Jason Rodriguez^*, Alberto De Iaco, PhD^*, James B. Rottman, PhD, DVM^*, Donghui Liu, PhD^*, Kartika Venugopal, PhD^*, Xin Qiao, MS^*, Yu Cao, PhD^*, Rebecca Levy, MS^*, Mohit Gupta, PhD^*, Rahul Palchaudhuri, PhD^*, Bill Querbes, PhD^*, Cecilia Cotta-Ramusino, PhD^*, Hari Pujar, PhD^*, Madhusudan V Peshwa, PhD^* and Michael C Holmes, PhD^*

Tessera Therapeutics, Somerville, MA

Elena Maroto Martin, PhD^1,2*, Yingjie Zhao^3*, Sara Mangesh Kolhatkar^1*, Roberto Garcia-Vicente^4*, Mubin Tarannum, PhD^5*, Mehmet K. Samur, PhD⁶, Mariateresa Fulciniti, PhD^1,2, Rizwan Romee, MD⁷, Jianzhu Chen^3* and Nikhil C. Munshi, MD^2,8

¹Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Harvard Medical School, Boston, MA
³Koch Institute For Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA
⁴Department of Translational Hematology, Research Institute Hospital 12 de Octubre (i+12), Hematological Malignancies Clinical Research Unit H120-CNIO, CIBERONC, Madrid, Spain
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁶Dana Farber Cancer Institute, Harvard Medical School, Boston, MA
⁷Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁸Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

John Goulding^1*, Mark Jelcic, PhD^1*, Daniel Morales-Mantilla, PhD^1*, John Reiser, PhD^2*, Alison O'Connor, MS^1*, Rina Mbofung, PhD^1*, Alan Williams, PhD^1*, Dan Lu, PhD^1*, Bi-Huei Yang, PhD^1*, Alma Gutierrez, MS^1*, Miguel Meza, BS^1*, Yijia Pan, PhD^1*, Jonatan Tuncel, PhD^1*, Bryan Hancock, PhD^1*, Sean Sherman, PhD^1*, Alec Witty, PhD^1*, Eigen Peralta, PhD^1*, Martin Hosking, PhD^1*, Lilly Wong, Ph.D.^1*, Tom Lee, PhD^1*, Jode Goodridge, PhD^1* and Bahram Valamehr, PhD¹

¹Fate Therapeutics, San Diego, CA
²Fate Therapeutics Inc. (FHQ1), San Diego, CA

Sanam Shahid, MD¹, Winson Cai^2*, Erin R. Burns^2*, Jasmine S. Um^2*, Serena Mathew^2*, Sydney Souness^2*, Sarah Yoo^2*, Bing-Yi Chen^2*, Takeshi Fujino^2*, Renier Brentjens, MD PhD³ and Anthony F. Daniyan, MD^4,5*

¹Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
²Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁴Department of Medicine, Cell Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

Wael Gamal, PhD^1,2, Nienke B. Goedhart, MSc^3,4,5*, Helga Simon-Molas, PhD^3,4,5*, Melanie Mediavilla Varela, PhD^2*, Angimar Uriepero Palma, MD, MMSc^6*, Fleur S. Peters, PhD^3,4,5*, Eva Sahakian, PhD^2,7*, Arnon P. Kater, MD, PhD^4,5 and Javier Pinilla-Ibarz, MD, PhD⁷

¹Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL
²Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
³Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
⁴Cancer Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands
⁵Department of Hematology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
⁶Department of Internal Medicine, Jefferson Einstein Hospital, Philadelphia, PA
⁷Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Robert Schwab, MD, MS¹, David Degaramo^1*, Daniel Brown, BSc^1*, Shawna Bookens, PhD^1*, John Keane^2*, Daniel Rader, MD^1* and Avery D. Posey, PhD^3*

¹University of Pennsylvania, Philadelphia, PA
²University of Pennsylvania, Philadelphai, PA
³Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA

Samy Jambon, PhD, PharmD^*, Jennifer Ruiz, BS^*, Andres Garcia-Maldonado, BA^*, Meixuan Chen, PhD^*, Danny Mendoza, BS^*, Garrett Arauz, BS^*, Nicholas DeMarco, BA^*, Mona Connerney, MD, PhD^*, Jeff D Eskew^*, Rajesh Belani, MD^*, Stacey A Cranert, PhD^*, Julia Coronella, PhD^* and Devon J Shedlock, PhD

Poseida Therapeutics, San Diego, CA

Siddarth Chandrasekaran^1*, Justin Yoo^2*, Dhaarini Murugan^1*, Laura Prochazka^3*, Elisa Martinez^3*, Michael Hunter Cadell^1*, Muluken S Belew^3*, Amanda AuYeung^3*, Chris Saxby^1*, Omar Subedar^3*, Zahra Sahaf^3*, Dylan Lee^3*, Sommer Apelu^1*, Libin Abraham^1*, Valerie Wall^1*, Chloe Hurling^3*, Vaisakh Rajan^3*, Shruti Sharma^3*, Charlie Liu^3*, Richard Carpenedo^3*, Shri Joshi^3*, Elizabeth Csaszar^3*, Emily Titus^3* and Chris Bond¹

¹Notch Therapeutics, Seattle
²Notch Therapeutics, Everett, WA
³Notch Therapeutics, Toronto, Canada

Jessica Maaskant, M.S.^1*, Anthony J Ross, M.D.², Karmella A Haynes, Ph.D.^3,4,5*, Alysa N Evans, B.S.^1*, Emily C Sullivan, B.S.^6*, Elizabeth P Weinzerl, M.D. Ph.D.^7*, Heather Lin, B.S.^1*, Dejah Blake, M.S.⁸, Liora Michal Schultz, M.D.⁹, Sunil S Raikar, M.D.^6,10, Sarwish Rafiq, PhD^8,11 and Curtis J Henry, Ph.D.^12,13

¹Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
²Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, IN
³3Walllace H. Coulter Department of Biomedical Engineering, Georgia Tech School of Engineering, Atlanta, GA
⁴Emory University School of Medicine, Atlanta, GA
⁵The Winship Cancer Institute, Atlanta, GA
⁶Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
⁷8Department of Pathology and Laboratory Medicine, Children’s Healthcare of Atlanta, Atlanta, GA
⁸Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
⁹Department of Pediatrics, Stanford University School of Medicine, Stanford, CA
¹⁰Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Emory University and Children's Healthcare of Atlanta, Atlanta, GA
¹¹Department of Hematology and Medical Oncology, Winship Cancer Institute, School of Medicine, Emory University, Atlanta, GA
¹²The University of Colorado Cancer Center, Aurora, CO
¹³Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora, CO

Ismail Can, PhD^1,2, R. Leo Sakemura, MD, PhD^1,2, Olivia L. Sirpilla, BS^1,3, Claudia Manriquez Roman, PhD^1,4*, Carli M. Stewart, BS^1,3, Kun Yun, BS, MSc^1,3, Truc Huynh^1,2*, Ekene Ogbodo, PhD^1,2*, Lionel A Kankeu Fonkoua, MD^5,6*, Jennifer M. Feigin^1,3, Omar Gutierrez Ruiz, PhD^1,2*, Long K. Mai^1,2*, Hong Xia, MD^1,2*, Brooke L. Kimball^1,2*, Mehrdad Hefazi, MD^1,2, Michael W. Ruff, MD^1,7*, Elizabeth L. Siegler, PhD^1,2, H. Atakan Ekiz^8*, Berke Alkan^9*, Fatih Sezer^8* and Saad S. Kenderian, MD^1,2

¹T Cell Engineering, Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN
⁴Center for Regenerative Biotherapeutics, Mayo Clinic, Rochester
⁵T Cell Engineering, Mayo Clinic, Rochester
⁶Department of Oncology, Mayo Clinic, Rochester
⁷Department of Neurology, Mayo Clinic, Rochester, MN
⁸Izmir Institute of Technology, Urla/İZmir, TUR
⁹Izmir Institute of Technology, Urla/Izmir, Turkey

Aalia N. Khan^1*, Jayant S. Goda, MD^2*, Sweety Asija^1*, Atharva Karulkar, PhD^3*, Pranoti Palkar^2*, Ambalika Chowdury^1*, Ankesh K. Jaiswal^1*, Deepti Phadnis^1*, Shreshtha Shah^3*, Afrin Firfiray^3*, Juber Pendhari^3*, Pranali Patil^3*, Nirali N. Shah, MD⁴, Manju Sengar, MD, DM⁵, Hasmukh Jain, MD, DM^5* and Rahul Purwar, PhD^1,3*

¹Department of Biosciences and Bioengineering, Indian Institute of Technology, Bombay, Mumbai, India
²Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Navi Mumbai, India
³Immunoadoptive Cell Therapy Private Limited (ImmunoACT), Mumbai, India
⁴Pediatric Oncology Branch, NIH, Bethesda, MD
⁵Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India

Jile Liu^1*, Xiaomei Zhang^2*, Rui Sun^2*, Shujing Guo^1*, Yuxin An, MD^1*, Yifan Zhao^1*, Mohan Zhao^3*, Hongkai Zhang^4* and Mingfeng Zhao^2,5

¹Tianjin First Central Hospital, Tianjin, China
²Medical School of Nankai University, Tianjin, China
³Tianjin First central hospital, Tianjin, China
⁴State Key Laboratory of Medicinal Chemical Biology and College of Life Science,, Tianjin, China
⁵Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China